These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 32090517)

  • 41. Liraglutide Does Not Adversely Impact Fat-Free Mass Loss.
    Grannell A; Martin WP; Dehestani B; Al-Najim W; Murphy JC; le Roux CW
    Obesity (Silver Spring); 2021 Mar; 29(3):529-534. PubMed ID: 33528919
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A 12-week treatment with the long-acting glucagon-like peptide 1 receptor agonist liraglutide leads to significant weight loss in a subset of obese women with newly diagnosed polycystic ovary syndrome.
    Jensterle M; Kravos NA; Pfeifer M; Kocjan T; Janez A
    Hormones (Athens); 2015; 14(1):81-90. PubMed ID: 25885106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A novel GIP analogue, ZP4165, enhances glucagon-like peptide-1-induced body weight loss and improves glycaemic control in rodents.
    Nørregaard PK; Deryabina MA; Tofteng Shelton P; Fog JU; Daugaard JR; Eriksson PO; Larsen LF; Jessen L
    Diabetes Obes Metab; 2018 Jan; 20(1):60-68. PubMed ID: 28598027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Primary care provider uptake of intensive behavioral therapy for obesity in Medicare patients, 2013-2019.
    Ozoor M; Gritz M; Dolor RJ; Holtrop JS; Luo Z
    PLoS One; 2023; 18(3):e0266217. PubMed ID: 36961786
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Zonisamide for weight loss in obese adults: a randomized controlled trial.
    Gadde KM; Franciscy DM; Wagner HR; Krishnan KR
    JAMA; 2003 Apr; 289(14):1820-5. PubMed ID: 12684361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial.
    Frøssing S; Nylander M; Chabanova E; Frystyk J; Holst JJ; Kistorp C; Skouby SO; Faber J
    Diabetes Obes Metab; 2018 Jan; 20(1):215-218. PubMed ID: 28681988
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effectiveness and tolerability of orlistat and liraglutide in patients with obesity in a real-world setting: The XENSOR Study.
    Gorgojo-Martínez JJ; Basagoiti-Carreño B; Sanz-Velasco A; Serrano-Moreno C; Almodóvar-Ruiz F
    Int J Clin Pract; 2019 Nov; 73(11):e13399. PubMed ID: 31397946
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In persons with obesity, exercise plus liraglutide improved weight-loss maintenance vs. exercise or placebo.
    Sarma S; Lipscombe LL
    Ann Intern Med; 2021 Sep; 174(9):JC102. PubMed ID: 34487446
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Liraglutide (Saxenda) for weight loss.
    Med Lett Drugs Ther; 2015 Jun; 57(1471):89-90. PubMed ID: 26079762
    [No Abstract]   [Full Text] [Related]  

  • 50. A randomized trial of lifestyle modification and taranabant for maintaining weight loss achieved with a low-calorie diet.
    Wadden TA; Fujioka K; Toubro S; Gantz I; Erondu NE; Chen M; Suryawanshi S; Carofano W; Johnson-Levonas AO; Shapiro DR; Kaufman KD; Heymsfield SB; Amatruda JM
    Obesity (Silver Spring); 2010 Dec; 18(12):2301-10. PubMed ID: 20379151
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study.
    Frandsen CS; Dejgaard TF; Holst JJ; Andersen HU; Thorsteinsson B; Madsbad S
    Diabetes Care; 2015 Dec; 38(12):2250-7. PubMed ID: 26486191
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Liraglutide: A Glucagon-Like Peptide-1 Agonist for Chronic Weight Management.
    Manigault KR; Thurston MM
    Consult Pharm; 2016 Dec; 31(12):685-697. PubMed ID: 28074747
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy and safety of beloranib for weight loss in obese adults: a randomized controlled trial.
    Kim DD; Krishnarajah J; Lillioja S; de Looze F; Marjason J; Proietto J; Shakib S; Stuckey BGA; Vath JE; Hughes TE
    Diabetes Obes Metab; 2015 Jun; 17(6):566-572. PubMed ID: 25732625
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacotherapy for obesity in individuals with type 2 diabetes.
    Chukir T; Shukla AP; Saunders KH; Aronne LJ
    Expert Opin Pharmacother; 2018 Feb; 19(3):223-231. PubMed ID: 29376439
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
    Greenway FL; Fujioka K; Plodkowski RA; Mudaliar S; Guttadauria M; Erickson J; Kim DD; Dunayevich E;
    Lancet; 2010 Aug; 376(9741):595-605. PubMed ID: 20673995
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The efficacy and safety of liraglutide in the obese, non-diabetic individuals: a systematic review and meta-analysis.
    Zhang P; Liu Y; Ren Y; Bai J; Zhang G; Cui Y
    Afr Health Sci; 2019 Sep; 19(3):2591-2599. PubMed ID: 32127832
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Pharmacotherapy for obesity].
    Bruun JM
    Ugeskr Laeger; 2016 Oct; 178(44):. PubMed ID: 27808050
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial.
    Fidler MC; Sanchez M; Raether B; Weissman NJ; Smith SR; Shanahan WR; Anderson CM;
    J Clin Endocrinol Metab; 2011 Oct; 96(10):3067-77. PubMed ID: 21795446
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Liraglutide after diet-induced weight loss for pain and weight control in knee osteoarthritis: a randomized controlled trial.
    Gudbergsen H; Overgaard A; Henriksen M; Wæhrens EE; Bliddal H; Christensen R; Nielsen SM; Boesen M; Knop FK; Astrup A; Rasmussen MU; Bartholdy C; Daugaard CL; Ellegaard K; Heitmann BL; Bartels EM; Danneskiold-Samsøe B; Kristensen LE
    Am J Clin Nutr; 2021 Feb; 113(2):314-323. PubMed ID: 33471039
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of liraglutide on body weight and pain in patients with overweight and knee osteoarthritis: protocol for a randomised, double-blind, placebo-controlled, parallel-group, single-centre trial.
    Gudbergsen H; Henriksen M; Wæhrens EE; Overgaard A; Bliddal H; Christensen R; Boesen MP; Knop FKK; Astrup A; Rasmussen MU; Bartholdy C; Daugaard C; Bartels EM; Ellegaard K; Heitmann BL; Kristensen LE
    BMJ Open; 2019 May; 9(5):e024065. PubMed ID: 31061017
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.